ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study to Evaluate the Long-Term Safety of M207 in the Acute Treatment of Migraine (ADAM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03282227
Recruitment Status : Active, not recruiting
First Posted : September 13, 2017
Last Update Posted : June 6, 2018
Sponsor:
Information provided by (Responsible Party):
Zosano Pharma Corporation

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : March 2019
  Estimated Study Completion Date : March 2019